Thank you
Dear Colleagues – Thank you for your participation!
On the behalf of Anna Giuliano & Peter Hillemanns, Congress Presidents and Joseph Monsonego, Chairman of the Scientific Committee, we would like to thank all of the EUROGIN 2022 attendees for their participation contributing to make this edition a success.
We hope you enjoyed the congress in Düsseldorf and you took advantage of the program and the opportunity to share knowledge and experience on HPV-related diseases.
We kindly remind you that the next EUROGIN congress is scheduled for February 8-11, 2023 in Bilbao (Spain).
We look forward to welcoming you next year.
Subscribe to our Newsletter and receive updates on the EUROGIN Conference
Workshop Francophone Virtuel 2022
Le cancer n'attend pas
CONTRÔLE EN VIE RÉELLE DES CANCERS HPV INDUITS -
ÉVIDENCES, PROGRÈS, DÉFIS ET PERSPECTIVES
Coordinateur scientifique: Joseph Monsonego
Testimonials 2022
I got a lot of new insights on HPV screening and management
Very clear on the new technologies using the latest studies in the field
My exchanges with patients will be more evidence-based
The conference will improve my diagnostic approach and management of the patients
I would like to congratulate you on an excellent and well-run conference
Our exhibitor participation at EUROGIN has been very successful
Sponsorship
For sponsorship and exhibition enquiries, please contact Peter Mattonet: [email protected]
Ethical Med Tech
The EUROGIN congress has been vetted as COMPLIANT by the Ethical Med Tech conference vetting system on all assessment criteria:
- Scientific Programme
- Geographic Location
- Conference Venue
- Hospitality
- Registration Packages
- Communication
EUROGIN (EUropean Research Organisation on Genital Infection and Neoplasia) brings together clinicians and scientists whose work is related to genital infections and neoplasia.
EUROVIR, owning the trademark EUROGIN, is a Trusted Partner of Ethical MedTech.